Download presentation
Presentation is loading. Please wait.
Published byBerna Özge Bozer Modified over 5 years ago
1
Chemotherapeutic Drug Combination Index Description
Drug Combination Study Summary (SU-DHL-8) Chemotherapeutic Drug CI (IC90) CI (IC75) CI (IC50) Combination Index Description Bleomycin 0.59 ± 0.04 0.53 ± 0.05 0.48 ± 0.06 Synergy Carboplatin 0.41 ± 0.11 0.47 ± 0.11 0.57 ± 0.11 Chlorambucil 0.73 ± 0.07 0.69 ± 0.07 0.65 ± 0.07 Moderate Synergy Doxorubicin 0.85 ± 0.05 0.76 ± 0.04 0.68 ± 0.04 Etoposide 0.79 ± 0.07 0.76 ± 0.10 0.75 ± 0.14 b Dacetuzumab upregulates Bid (Ramos) Bid 22 kDa C D 0.33 2 4 6 8 24 32 48 56 Hours Supplementary Figure 3 Lewis, et al.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.